Skip to main content
. Author manuscript; available in PMC: 2015 Jul 22.
Published in final edited form as: Ann Rheum Dis. 2014 Jan 7;74(5):830–835. doi: 10.1136/annrheumdis-2013-203967

Table 4.

Distribution of the ASAS HI sum score stratified on different disease activity and functioning levels

Group I (0–3.9)*
BASDAI (n=146)		 Group II (4–6)*
BASDAI (n=166)		 Group III (6.1–10)*
BASDAI (n=293)
ASAS HI mean±SD 5.0±3.2 7.4±3.1 10.6±3.0
Group I (0–3.9)* Group II (4–6)* Group III (6.1–10)*
BASFI (n=256) BASFI (n=152) BASFI (n=195)
ASAS HI, mean±SD 5.7±3.0 8.5±2.8 11.7±2.8
Group I (0–3.9)* Group II (4–7)* Group III (7.1–10)*
Total back pain (n=205) Total back pain (n=264) Total back pain (n=131)
ASAS HI, mean±SD 5.6±3.4 9.0±3.1 11.4±2.9
*

On a numerical rating scale of 0–10.

BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; ASAS HI, Assessment of SpondyloArthritis international Society Health Index.